前往化源商城

吡美莫司

更新时间:2025-08-25 16:34:42

吡美莫司结构式
吡美莫司结构式
品牌特惠专场
常用名 吡美莫司 英文名 Pimecrolimus
CAS号 137071-32-0 分子量 810.453
密度 1.2±0.1 g/cm3 沸点 866.1±75.0 °C at 760 mmHg
分子式 C43H68ClNO11 熔点 N/A
MSDS 中文版 美版 闪点 477.6±37.1 °C

 吡美莫司用途


Pimecrolimus是免疫亲和素(immunophilin)配体,能特异地与胞质受体(immunophilin macrophilin-12)相结合。

 吡美莫司名称

中文名 吡美莫司
英文名 Pimecrolimus
中文别名 匹美克莫司
英文别名 更多

 吡美莫司物理化学性质

密度 1.2±0.1 g/cm3
沸点 866.1±75.0 °C at 760 mmHg
分子式 C43H68ClNO11
分子量 810.453
闪点 477.6±37.1 °C
精确质量 809.448120
PSA 158.13000
LogP 5.08
外观性状 白色结晶粉末
蒸汽压 0.0±0.6 mmHg at 25°C
折射率 1.543
储存条件 -20°C Freezer

 吡美莫司安全信息

危害码 (欧洲) Xi
危险品运输编码 NONH for all modes of transport

 吡美莫司合成线路

~47%

吡美莫司结构式

吡美莫司

137071-32-0

文献:Grassberger, Maximilian; Horvath, Amarylla Patent: US2008/71082 A1, 2008 ; Location in patent: Page/Page column 3 ;

~%

吡美莫司结构式

吡美莫司

137071-32-0

文献:WO2006/60614 A1, ; Page/Page column 13 ;

~39%

吡美莫司结构式

吡美莫司

137071-32-0

文献:Ferraboschi, Patrizia; Colombo, Diego; De Mieri, Maria; Grisenti, Paride Tetrahedron Letters, 2009 , vol. 50, # 30 p. 4384 - 4388

 吡美莫司上下游产品

吡美莫司上游产品  2

吡美莫司下游产品  0

 吡美莫司英文别名

Pimecrolimus
Elidel,SDZ-ASM-981
33-epi-33-chloro-FR 520
SDZ-ASM 981
Elidel
33-epi-chloro-33-desoxy-ascomycin
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-{(1E)-1-[(1R,3R,4S)-4-Chloro-3-methoxycyclohexyl]-1-propen-2-yl}-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatri ;cyclo[22.3.1.0]octacos-18-ene-2,3,10,16-tetrone
15,19-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 3-[(E)-2-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]-1-methylethenyl]-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-
Picrolimus
ASM 981
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
品牌现货直购
推荐供应商:







查看所有供应商和价格请点击:

吡美莫司生产厂家

吡美莫司价格

相关化合物: 更多...
吡美莫司杂质9
1025113-89-6
萘吡莫司
70696-66-1
吡美辛
79992-71-5
吡美诺
68252-19-7
吡莫地韦
1629869-44-8
匹美克莫司水合物
1000802-56-1
西美莫辛
3788-16-7
拉氟莫司
147076-36-6
FK506-13C,d2
1356841-89-8
lithium;(2R)-2-[[1-(benzenesulfonyl)pyrrolo[2,3-b]pyridin-2-yl]methyl]pyrrolidine-1-sulfonate
1008108-76-6
Glycine, N-methyl-N-[(phenylamino)thioxomethyl]-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-, methyl ester
1038781-12-2
3-chloro-5-[(1,5-dimethyl-1H-pyrazol-3-yl)methyl]-1,2,3,6-tetrahydropyridine
2137885-85-7
(E)-but-2-enedioic acid;N-(4-imidazol-1-ylbutyl)-1H-benzo[cd]indol-2-imine
112102-38-2
3-Oxazolidinepentanoic acid,-[(S)-[(4-fluorophenyl)amino][4-(2-propen-1-yloxy)phenyl]methyl]-,2-dioxo-4-phenyl-, phenylmethyl ester, (R,4S)-
1202579-22-3
4-O-tert-butyl 1-O-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanedioate
1202710-63-1
[1,1'-Biphenyl]-4-propanoic acid,-(acetylamino)-, (R)-, compd. with (S)--methylbenzenemethanamine (1:1)
1236479-65-4
tert-butyl N-[(2S)-1-[[(1S)-2-[(2S)-2-carbamoyl-3-[(1S,2R)-2-[6-[[(1S,2R)-1-[(2S)-2-carbamoyl-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]propanoyl]amino]acetyl]pyrrolidin-3-yl]-2,3-dihydro-1H-inden-2-yl]oxy]hexa-2,4-diynoxy]-2,3-dihydro-1H-inden-1-yl]pyrrolidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]-1-oxopropan-2-yl]-N-methylcarbamate
1258392-64-1
[4-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]amino]phenyl]methyl (6S,6aS)-3-[5-[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]pentoxy]-6-hydroxy-2-methoxy-8-methylidene-11-oxo-6,6a,7,9-tetrahydropyrrolo[2,1-c][1,4]benzodiazepine-5-carboxylate
1343476-22-1
methyl 2-(3-aminopropoxy)-4-[(E)-3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoate;hydrochloride
1351169-37-3